Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension

OBJECTIVE: The aim was to assess the effects of prolonged release oxycodone/naloxone (OXN PR) on sleep and quality of life (QoL) in patients with severe restless legs syndrome (RLS) refractory to first-line dopaminergic RLS treatment. METHODS: Sleep and QoL data from a 12-week, randomized, double-bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Oertel, Wolfgang H., Hallström, Yngve, Saletu-Zyhlarz, Gerda M., Hopp, Michael, Bosse, Björn, Trenkwalder, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982896/
https://www.ncbi.nlm.nih.gov/pubmed/27401882
http://dx.doi.org/10.1007/s40263-016-0372-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982896/
https://www.ncbi.nlm.nih.gov/pubmed/27401882
http://dx.doi.org/10.1007/s40263-016-0372-1

Ejemplares similares